학술논문
Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology June 2024 12(6):380-389
Subject
Language
ISSN
2213-8587